OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
813859

Sankyo Kasei Corp

Commodity ChemicalsVerified

Sankyo Kasei Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.08, significantly below the industry median of 0.35, indicating a low leverage profile. The company's liquidity position is robust, with a current ratio of 1.69 and cash and equivalents of ¥1.47 billion, which provides a buffer against short-term obligations. However, the operating cash flow of -¥666 million suggests operational inefficiencies or working capital constraints that may require monitoring. Profitability metrics show a return on equity (ROE) of 7.22% and a return on assets (ROA) of 3.89%, both below the industry medians of 10.5% and 5.2%, respectively. The operating margin of 1.7% is also below the median of 3.1%, indicating that the company is underperforming in converting revenue into operating profit. The net profit margin of 2.32% further highlights the need for cost optimization or pricing power improvement. The company's revenue is split between two segments: Science and Building Materials. The Science segment, which includes chemical raw materials and industrial chemicals, is likely the primary revenue driver, though the exact contribution is not disclosed. Geographically, the company is concentrated in Japan, with no material international operations reported, which may limit growth potential and expose it to domestic economic fluctuations. Looking ahead, the company's revenue is projected to remain stable, with no significant growth expected in the next fiscal year. The capital expenditure of -¥10.5 million suggests minimal investment in expansion or modernization, which may affect long-term competitiveness. The company's free cash flow of ¥606 million provides flexibility for dividends or strategic investments, but the lack of capital spending may signal a conservative approach to growth. Risk factors include the low liquidity score and the potential for operational inefficiencies, as indicated by the negative operating cash flow. The dilution risk is currently low, with no immediate filing-based flags detected, and the number of shares outstanding has remained unchanged between basic and diluted shares. The company's conservative capital structure and low debt levels mitigate credit risk, but the low ROE and ROA suggest that management may need to improve asset utilization and profitability. Recent filings and transcripts do not indicate any material events or strategic shifts, and the company's financial performance appears to be in line with analyst estimates for revenue and EPS. The absence of significant news or regulatory actions suggests a stable but unremarkable operating environment.

30-day price · 8138(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySankyo Kasei Corp
Ticker8138.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Sankyo Kasei Corp operates in the science and building materials sectors, deriving revenue from the sale of chemical raw materials and housing components.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Sankyo Kasei Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.08, significantly below the industry median of 0.35, indicating a low leverage profile. The company's liquidity position is robust, with a current ratio of 1.69 and cash and equivalents of ¥1.47 billion, which provides a buffer against short-term obligations. However, the operating cash flow of -¥666 million suggests operational inefficiencies or working capital constraints that may require monitoring. Profitability metrics show a return on equity (ROE) of 7.22% and a return on assets (ROA) of 3.89%, both below the industry medians of 10.5% and 5.2%, respectively. The operating margin of 1.7% is also below the median of 3.1%, indicating that the company is underperforming in converting revenue into operating profit. The net profit margin of 2.32% further highlights the need for cost optimization or pricing power improvement. The company's revenue is split between two segments: Science and Building Materials. The Science segment, which includes chemical raw materials and industrial chemicals, is likely the primary revenue driver, though the exact contribution is not disclosed. Geographically, the company is concentrated in Japan, with no material international operations reported, which may limit growth potential and expose it to domestic economic fluctuations. Looking ahead, the company's revenue is projected to remain stable, with no significant growth expected in the next fiscal year. The capital expenditure of -¥10.5 million suggests minimal investment in expansion or modernization, which may affect long-term competitiveness. The company's free cash flow of ¥606 million provides flexibility for dividends or strategic investments, but the lack of capital spending may signal a conservative approach to growth. Risk factors include the low liquidity score and the potential for operational inefficiencies, as indicated by the negative operating cash flow. The dilution risk is currently low, with no immediate filing-based flags detected, and the number of shares outstanding has remained unchanged between basic and diluted shares. The company's conservative capital structure and low debt levels mitigate credit risk, but the low ROE and ROA suggest that management may need to improve asset utilization and profitability. Recent filings and transcripts do not indicate any material events or strategic shifts, and the company's financial performance appears to be in line with analyst estimates for revenue and EPS. The absence of significant news or regulatory actions suggests a stable but unremarkable operating environment.
Key takeaways
  • Sankyo Kasei Corp has a low debt-to-equity ratio of 0.08, indicating a conservative capital structure.
  • The company's ROE of 7.22% and ROA of 3.89% are below industry medians, suggesting underperformance in profitability.
  • Revenue is concentrated in Japan with no material international operations, limiting growth potential.
  • Free cash flow of ¥606 million provides flexibility, but minimal capital expenditure may affect long-term competitiveness.
  • The company's liquidity and dilution risks are currently low, but operational inefficiencies need monitoring.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$27.12B
Gross profit$2.57B
Operating income$459.2M
Net income$629.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$666.3M
CapEx-$10.5M
Free cash flow$606.0M
Total assets$16.18B
Total liabilities$7.47B
Total equity$8.71B
Cash & equivalents$1.47B
Long-term debt$720.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.71B
Net cash$748.7M
Current ratio1.7
Debt/Equity0.1
ROA3.9%
ROE7.2%
Cash conversion-1.1%
CapEx/Revenue-0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric8138Activity
Op margin1.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin9.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity8.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS497.66 JPY
Last actual revenue27,117,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 13:48 UTC#3c0b8d79
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 14:38 UTCJob: 203a7d11